ADB-BINACA

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

ADB-BINACA (also known as ADMB-BZINACA using EMCDDA naming standards ) is a cannabinoid designer drug that has been found as an ingredient in some synthetic cannabis products. It was originally developed by Pfizer as a potential analgesic, and is a potent agonist of the CB 1 receptor with a binding affinity (K i ) of 0.33 nM and an EC 50 of 14.7 nM.

ADB-BINACA (also known as ADMB-BZINACA using EMCDDA naming standards ) is a cannabinoid designer drug that has been found as an ingredient in some synthetic cannabis products. It was originally developed by Pfizer as a potential analgesic, and is a potent agonist of the CB 1 receptor with a binding affinity (K i ) of 0.33 nM and an EC 50 of 14.7 nM.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1340547498 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

1 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.